The epidemiology and burden of COPD in latin America and the caribbean: Systematic review and meta-analysis

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 3, 2014, Pages 339-350

  Ciapponi, Agustín ^a   Alison, Lee ^a   Agustina, Mazzoni ^a   Demián, Glujovsky ^a   Silvana, Cesaroni ^a   Edgardo, Sobrino ^a  

^a INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

Author keywords

Adult; Cost of illness; Population surveillance; Prevalence

Indexed keywords

ARTICLE; CENTRAL AMERICA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; HEALTH CARE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; SYSTEMATIC REVIEW; AGE; CARIBBEAN; COMORBIDITY; DISEASE COURSE; ECONOMICS; HEALTH SERVICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX DIFFERENCE; UTILIZATION;

AGE FACTORS; CARIBBEAN REGION; COMORBIDITY; DISEASE PROGRESSION; HEALTH SERVICES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LATIN AMERICA; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS;

EID: 84900811201     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.836479     Document Type: Article

References (60)

1. WHO. Chronic obstructive pulmonary disease (COPD) Geneva, : World Health Organization; 2012 [cited 2012 December 23 2012]. Available from: http://www.who.int/respiratory/copd/en/index.html.
2. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007 Oct 1; 4(7):502-506. PubMed PMID: 17878461. (Pubitemid 47547843)
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006 Nov; 3(11):e442. PubMed PMID: 17132052.
4. Ait-Khaled N, Enarson DA, Ottmani S, et al. Chronic air flow limitation in developing countries: Burden and priorities. Inter J Chron Obstruct Pulm Dis 2007; 2(2):141-150. PubMed PMID: 18044686. (Pubitemid 47202214)
5. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000 Apr 19; 283(15):2008-12. PubMed PMID: 10789670. (Pubitemid 30214957)
6. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 2009 Jul 21; 6(7):e1000100. PubMed PMID: 19621070.
7. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009 Jul 21; 6(7):e1000097. PubMed PMID: 19621072.
8. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2011. Available from: http://www.goldcopd.org/uploads/users/files/GOLD-Report-2011- Feb21.pdf.
9. Celli BR, MacNee W, Force AET. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ ERS position paper. Eur Respir J 2004 Jun; 23(6):932-946. PubMed PMID: 15219010. (Pubitemid 38807371)
10. Ciapponi A, Glujovsky D, Bardach A, et al., editors. EROS: A new software for early stage of systematic reviews. HTAi 2011 Conference; 2011 27-29th June, 2011; Rio de Janeiro, Brazil.
11. Ciapponi A, Glujovsky D, Bardach A, et al., editors. EROS: A new software for early stage of systematic reviews. ISPOR 3rd Latin America Conference; 2011 8-10 September 2011; Hilton Mexico City Reforma in Mexico City, Mexico.
12. Glujovsky D, Bardach A, García Martí S, et al., editors. New Software for Early Stage of Systematic Reviews. XVIII Cochrane Colloquium The Joint Colloquium of the Cochrane & Campbell Collaborations; 2010 18-22 October 2010; Keystone Resort, Colorado, USA.
13. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007 Oct 20; 370(9596):1453-1457. PubMed PMID: 18064739.
14. Wong WC, Cheung CS, Hart GJ. Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg Themes Epidemiol 2008; 5:23. PubMed PMID: 19014686.
15. Berra S, Elorza-Ricart JM, Estrada M-D, et al. Instrumento para la lectura crítica y la evaluación de estudios epidemiológicos transversales. Gaceta Sanitaria 2008; 22:492-497.
16. Fowkes FG, Fulton PM. Critical appraisal of published research: Introductory guidelines. BMJ 1991 May 11; 302(6785):1136-1140. PubMed PMID: 2043787.
17. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography. Int J Epidemiol 2007 Jun; 36(3):666-676. PubMed PMID: 17470488. (Pubitemid 47244573)
18. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat 1950; 21:607-611.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 Sep; 7(3):177-188. PubMed PMID: 3802833. (Pubitemid 17189972)
20. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003 Sep 6; 327(7414):557-560. PubMed PMID: 12958120. (Pubitemid 37088507)
21. Caballero A, Torres-Duque CA, Jaramillo C, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest 2008 Feb; 133(2):343-349. PubMed PMID: 2008090792. (Pubitemid 351272390)
22. Menezes A, Macedo SC, Gigante DP, et al. Prevalence and risk factors for chronic obstructive pulmonary disease according to symptoms and spirometry. COPD 2004; 1(2):173-179. PubMed PMID: 17136985.
23. Laniado-Laborin R. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health 2009 Jan; 6(1):209-224. PubMed PMID: 19440278.
24. Chatkin G, Chatkin JM, Aued G, et al. Evaluation of the exhaled carbon monoxide levels in smokers with COPD. J Bras Pneumol 2010 Jun; 36(3):332-338. PubMed PMID: 20625671.
25. Menezes AMB, Perez-Padilla R, Jardim JRB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet 2005 Nov 26;366(9500):1875-1881. PubMed PMID: 2005536833. (Pubitemid 41690116)
26. Seemungal T, Harrinarine R, Rios M, et al. Obstructive lung disease in acute medical patients. West Indian Med J 2008 Jan; 57(1):7-13. PubMed PMID: 19565931. (Pubitemid 351722292)
27. Faganello MM. Fatores associados à ocorrência de exacerbação em pacientes com DPOC. Botucatu: s.n; 2007.
28. Ramirez-Venegas A, Sansores RH, Perez-Padilla R, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006 Feb 15; 173(4):393-397. PubMed PMID: 16322646. (Pubitemid 43228326)
29. Rico-Méndez FG, Barquera S, Múgica-Hernández JJ, et al. [Survival in a cohort of patients with chronic obstructive pulmonary disease: comparison between primary and tertiary levels of care]. Archivos de bronconeumología [Internet] 2005; (5):[260-266 pp.]. Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/146/ CN-00522146/frame.html. (Pubitemid 41227433)
30. Godoy DVd, Dal Zotto C, Bellicanta J, et al. Doenças respiratórias como causa de internações hospitalares de pacientes do Sistema Unico de Saúde num serviço terciário de clínica médica na região nordeste do Rio Grande do Sul. J Pneumol 2001; 27(4):193-198. PubMed PMID: 339742.
31. Miravitlles M, Jardim JR, Zitto T, et al. [Pharmaco economic study of antibiotic therapy for exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in Latin America]. Arch Bronconeumol 2003 Dec; 39(12):549-553. PubMed PMID: 14636491. (Pubitemid 38004941)
32. Lopez Varela MV, Muino A, Perez Padilla R, et al. Treatment of chronic obstructive pulmonary disease in 5 Latin American Cities: The PLATINO study. [Spanish]. Arch Bronconeumol 2008 Feb; 44(2):58-64. PubMed PMID: 2008233735.
33. Dias-da-Costa JS, De Borba LG, Pinho MN, et al. Quality of primary care as measured by preventable hospitalizations in the South of Brazil. [Portuguese] Qualidade da atencao basica mediante internacoes evitaveis no Sul do Brasil. Cadernos de Saude Publica 2008; (7):1699-1707. PubMed PMID: 18670693.
34. Duran D, Vargas OC. Stable copd management in relation to the GOLD: Experience at a university hospital. Colombia Medica 2008; (4):328-345. PubMed PMID: 2009177981.
35. Miravitlles M, Murio C, Tirado-Conde G, et al. Geographic differences in clinical characteristics and management of COPD: The EPOCA study. Inter J COPD 2008; 3(4):803-814. PubMed PMID: 2009077581.
36. Arredondo A, Carrillo C, Zuniga A. Economic burden of expected epidemiological changes in diseases related to tobacco, Mexico. Rev Saude Publica 2007 Aug; 41(4):523-529. PubMed PMID: 17589749.
37. Pérez N, Murillo R, Pinzón C, et al. Costos de la atención médica del cáncer de pulmón, la EPOC y el IAM atribuibles al consumo de tabaco en Colombia (proyecto multicéntrico de la OPS). Rev Colomb Cancerol 2007; 11(4):241-249. PubMed PMID: 493088.
38. Martínez-Gutiérrez MS, Vanegas L J, Reveco U S, et al. Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago. Rev méd Chile 2008; 136(10):1281-1287. PubMed PMID: 503895.
39. Reynales-Shigematsu LM, Juarez-Marquez SA, Valdes-Salgado R. Costs of medical care attributable to tobacco consumption at the Mexican Institute of Social Security (IMSS), Morelos. [Spanish]. Salud Publica de Mexico 2005 Nov; 47(6):451-457. PubMed PMID: 2006064805. (Pubitemid 43187096)
40. Reynales-Shigematsu LM, Rodriguez-Bolanos Rde L, Jimenez JA, et al. [Health care costs attributable to tobacco consumption on a national level in the Mexican Social Security Institute]. Salud Publica Mex 2006; 48 Suppl 1:S48-64. PubMed PMID: 17684689. (Pubitemid 44668651)
41. Castro HA, Goncalves KS, Hacon SS. Trend of mortality from respiratory disease in elderly and the forest fi res in the state of Rondonia/Brazil - period between 1998 and 2005. [Portuguese]. Ciencia Saude Coletiva 2009; 14(6):2083-2090. PubMed PMID: 0020069176.
42. Sivori M, Saenz CB, Posse CR. Mortalidad por asma y enfermedad pulmonar obstructiva crónica en Argentina en el periodo 1980-1998. Medicina (BAires) 2001; 61(5, pt.1):513-521. PubMed PMID: 299672. (Pubitemid 33741739)
43. Campos HS. Mortalidade por DPOC no Brasil, 1980-1998. Pulmão RJ 2003; 12(4):217-225. PubMed PMID: 401665.
44. Montes de Oca M, Talamo C, Halbert RJ, et al. Frequency of self-reported COPD exacerbation and air flow obstruction in five latin American cities: The Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study. Chest 2009; 136(1):71-78. PubMed PMID: 2009370476.
45. Dreyse DJ, Lisboa BC, Pinto RC, et al. Características clínicas y funcionales según género de pacientes con enfermedad pulmonary obstructiva crónica. Rev Chil Enferm Respir 2008; (2):95-100.
46. Laniado-Laborin R, Rendon A, Bauerle O. High copd prevalence in mexico: A prevalence study. CHEST Journal. 2009;136(4-MeetingAbstracts):90S-S.
47. Seemungal T, Harrinarine R, Rios M, et al. Obstructive lung disease in acute medical patients. West Ind Med J 2008; (1):7-13. PubMed PMID: 19565931. (Pubitemid 351722292)
48. Toyoshima MTK, Ito GM, Gouveia N. Morbidade por doencas respiratórias em pacientes hospitalizados em São Paulo/ SP. Revista da Associação Médica Brasileira (1992) 2005; 51(4):209-213. PubMed PMID: 411208. (Pubitemid 44699523)
49. Information System of the Brazilian Ministry of Health (DATASUS) [May 2011]. Available from: www.datasus.gov.br.
50. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: Systematic review and meta-analysis. Eur Respir J 2006 Sep; 28(3):523-532. PubMed PMID: 16611654. (Pubitemid 44794666)
51. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006 Jan; 27(1):188-207. PubMed PMID: 16387952. (Pubitemid 43092683)
52. Lopez Varela MV, Montes de Oca M, Halbert RJ, et al. Sexrelated differences in COPD in five Latin American cities: The PLATINO study. Eur Respir J 2010 Nov; 36(5):1034-1041. PubMed PMID: 20378599.
53. Xu X, Weiss ST, Rijcken B, et al. Smoking, changes in smoking habits, and rate of decline in FEV1: New insight into gender differences. Eur Respir J 1994 Jun; 7(6):1056-1061. PubMed PMID: 7925873. (Pubitemid 24187324)
54. Bellamy D, Smith J. Role of primary care in early diagnosis and effective management of COPD. Inter J Clin Pract 2007; 61(8):1380-1389. PubMed PMID: 17627713. (Pubitemid 47052369)
55. Moreno Bolton R, González González P. Manejo ambulatorio de la EPOC: informe de una Reunión de Consenso. Rev Méd Chile 1999; 127(2):229-234. PubMed PMID: 243784.
56. Duran D, Vargas OC. Stable copd management in relation to the GOLD: Experience at a university hospital. Colombia Med 2008; 39(4):328-345. PubMed PMID: 2009177981.
57. Jones R, Ostrem A. Optimising pharmacological maintenance treatment for COPD in primary care. Prim Care Respir J: J Gen Pract Airways Group 2011 Mar; 20(1):33-45. PubMed PMID: 21103801.
58. Wilson LM, Avila Tang E, Chander G, et al. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: A systematic review. J Environ Publ Health 2012; 2012:961724. PubMed PMID: 22719777.
59. WHO. Chronic obstructive pulmonary disease (COPD) Geneva, World Health Organization; 2000.
60. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001 Apr; 163(5):1256-1276. PubMed PMID: 11316667. (Pubitemid 32378468)